dividends
RD
NYSE · RDY
Dr. Reddy's Laboratories Limited
Healthcare · Drug Manufacturers - Specialty & Generic
$11.55
Up+$0.11 (+0.91%)
Updated Sep 16, 2026, 7:03 PM
SID Score
5.2/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 11.73B
- P/E ratio
- 18.22
- Dividend yield
- 0.79%
- 52-week range
- $11.36 – $15.67
- Volume
- 4.23M
- Avg. volume
- 1.06M
Price performance
RDY price history
1M range · 20 trading sessions · Daily adjusted prices
RDY closed at $11.55 after 20 trading sessions, down 4.94% for the selected period.
- Last close
- $11.55
- Period change
- -4.94%
- Period low
- $11.55
- Period high
- $12.34
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $11.80 | $11.82 | $11.51 | $11.55 | 4.23M |
| Sep 14, 2026 | $11.93 | $11.94 | $11.865 | $11.91 | 2.41M |
| Sep 11, 2026 | $11.92 | $12.03 | $11.89 | $11.90 | 3.14M |
| Sep 10, 2026 | $11.86 | $11.86 | $11.67 | $11.71 | 2.93M |
| Sep 9, 2026 | $11.87 | $11.97 | $11.825 | $11.88 | 3.5M |
| Sep 8, 2026 | $11.78 | $11.90 | $11.69 | $11.88 | 2.13M |
| Sep 4, 2026 | $12.01 | $12.06 | $11.905 | $11.97 | 2.34M |
| Sep 3, 2026 | $12.05 | $12.17 | $11.92 | $12.03 | 5.51M |
| Sep 2, 2026 | $12.12 | $12.205 | $12.12 | $12.17 | 4.01M |
| Sep 1, 2026 | $12.21 | $12.28 | $12.15 | $12.17 | 1.93M |
| Aug 31, 2026 | $12.01 | $12.215 | $12.01 | $12.13 | 2.16M |
| Aug 28, 2026 | $12.33 | $12.33 | $12.115 | $12.18 | 1.67M |
| Aug 27, 2026 | $12.18 | $12.235 | $12.13 | $12.16 | 1.55M |
| Aug 26, 2026 | $12.25 | $12.30 | $12.135 | $12.22 | 1.67M |
| Aug 25, 2026 | $12.28 | $12.375 | $12.22 | $12.34 | 1.77M |
| Aug 24, 2026 | $12.24 | $12.25 | $12.13 | $12.22 | 2.07M |
| Aug 21, 2026 | $12.13 | $12.225 | $12.065 | $12.18 | 2.02M |
| Aug 20, 2026 | $12.12 | $12.23 | $12.05 | $12.11 | 2.55M |
| Aug 19, 2026 | $12.17 | $12.215 | $11.99 | $12.11 | 3.26M |
| Aug 18, 2026 | $12.12 | $12.21 | $12.06 | $12.15 | 3.07M |
Latest RDY news
The latest Smart Investors Daily articles mentioning RDY.
Stock researchResearch & News · SEC Filings
Loading stock research…